Rezolute (RZLT) Asset Writedowns and Impairment (2018 - 2020)
Rezolute (RZLT) posted Asset Writedowns and Impairment of $23000.0 for Q2 2020, up 91.67% sequentially from $12000.0 in Q2 2019, and up 91.67% YoY from $12000.0 in Q3 2019.
Analysis
Rezolute (RZLT) Asset Writedowns and Impairment (2018 - 2020) Analysis & Trends
Rezolute has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $23000.0 in Q2 2020.
- Quarterly Asset Writedowns and Impairment rose 91.67% year-over-year to $23000.0 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $35000.0 (down 97.98% YoY) and the FY2020 annual result came in at $23000.0, down 48.89% from the prior year.
- Asset Writedowns and Impairment grew to $23000.0 in Q2 2020 per RZLT's latest filing, from $12000.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $1.7 million in Q2 2018 and troughed at $12000.0 in Q2 2019.
- A 3-year average of $439750.0 and a median of $28000.0 in 2018 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2019 and 2020: Asset Writedowns and Impairment sank 99.29% in 2019, then soared 91.67% in 2020.
- Over 3 years, Asset Writedowns and Impairment stood at $33000.0 in 2018, then plunged by 63.64% to $12000.0 in 2019, then surged by 91.67% to $23000.0 in 2020.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $23000.0, $12000.0, and $33000.0 for Q2 2020, Q2 2019, and Q4 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Rezolute | 477.02 Mn | 477.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 23,000.00 |
| Jun 30, 2019 | 12,000.00 |
| Dec 31, 2018 | 33,000.00 |
| Jun 30, 2018 | 1.69 Mn |